Anchor Capital Advisors LLC lowered its holdings in American Healthcare REIT, Inc. (NYSE:AHR – Free Report) by 1.5% during the second quarter, HoldingsChannel.com reports. The institutional investor owned 167,065 shares of the company’s stock after selling 2,463 shares during the period. Anchor Capital Advisors LLC’s holdings in American Healthcare REIT were worth $6,138,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Stratos Wealth Partners LTD. grew its holdings in shares of American Healthcare REIT by 57.9% during the 1st quarter. Stratos Wealth Partners LTD. now owns 16,070 shares of the company’s stock worth $487,000 after purchasing an additional 5,891 shares in the last quarter. GAMMA Investing LLC grew its holdings in shares of American Healthcare REIT by 42.2% during the 1st quarter. GAMMA Investing LLC now owns 1,405 shares of the company’s stock worth $43,000 after purchasing an additional 417 shares in the last quarter. Envestnet Portfolio Solutions Inc. acquired a new stake in shares of American Healthcare REIT during the 2nd quarter worth approximately $207,000. Charles Schwab Investment Management Inc. grew its holdings in shares of American Healthcare REIT by 4.2% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 2,235,051 shares of the company’s stock worth $67,722,000 after purchasing an additional 89,926 shares in the last quarter. Finally, Beacon Financial Advisory LLC acquired a new stake in shares of American Healthcare REIT during the 2nd quarter worth approximately $230,000. Institutional investors and hedge funds own 16.68% of the company’s stock.
Insider Activity at American Healthcare REIT
In other American Healthcare REIT news, EVP Mark E. Foster sold 3,850 shares of the business’s stock in a transaction dated Wednesday, September 3rd. The stock was sold at an average price of $41.89, for a total value of $161,276.50. Following the completion of the transaction, the executive vice president directly owned 59,100 shares of the company’s stock, valued at approximately $2,475,699. The trade was a 6.12% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.92% of the stock is currently owned by company insiders.
American Healthcare REIT Stock Up 2.5%
American Healthcare REIT (NYSE:AHR – Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The company reported $0.42 EPS for the quarter, topping analysts’ consensus estimates of $0.40 by $0.02. American Healthcare REIT had a negative return on equity of 1.43% and a negative net margin of 1.56%.The business had revenue of $542.50 million during the quarter, compared to analysts’ expectations of $539.49 million. During the same period in the previous year, the firm earned $0.33 earnings per share. The firm’s quarterly revenue was up 7.5% compared to the same quarter last year. On average, equities research analysts forecast that American Healthcare REIT, Inc. will post 1.41 EPS for the current year.
American Healthcare REIT Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, October 17th. Investors of record on Tuesday, September 30th were paid a dividend of $0.25 per share. The ex-dividend date of this dividend was Tuesday, September 30th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.1%. American Healthcare REIT’s payout ratio is -454.55%.
Wall Street Analysts Forecast Growth
Several analysts have recently weighed in on AHR shares. KeyCorp lifted their price objective on American Healthcare REIT from $40.00 to $43.00 and gave the stock an “overweight” rating in a report on Tuesday, October 14th. Royal Bank Of Canada lifted their price objective on American Healthcare REIT from $39.00 to $45.00 and gave the stock an “outperform” rating in a report on Wednesday, August 13th. Scotiabank reissued an “outperform” rating on shares of American Healthcare REIT in a report on Thursday, August 28th. Zacks Research raised American Healthcare REIT from a “hold” rating to a “strong-buy” rating in a report on Friday, October 17th. Finally, JMP Securities raised their target price on American Healthcare REIT from $45.00 to $50.00 and gave the stock a “market outperform” rating in a research report on Friday, October 17th. Two research analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus price target of $45.00.
View Our Latest Research Report on AHR
About American Healthcare REIT
Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.
Read More
- Five stocks we like better than American Healthcare REIT
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- 3 Cash-Rich Stocks With High Growth Potential Right Now
- Top Biotech Stocks: Exploring Innovation Opportunities
- Why Vertical Aerospace Stock Could Double After This Flight Test
- What Are the FAANG Stocks and Are They Good Investments?
- Amazon: Breakout Confirmed—Here’s Where It Could Go Next
Want to see what other hedge funds are holding AHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for American Healthcare REIT, Inc. (NYSE:AHR – Free Report).
Receive News & Ratings for American Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.
